The second one remarkably showed a lower prevalence of CRC in NAFLD patients but a higher risk for CRC in the presence of insulin resistance; however it is well known that both raised alanine aminotransferase (ALT) levels and ultrasound can underestimate the diagnosis of NAFLD. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.